A new strategy to counter insulin damage in coronary artery disease

April 29, 2020

By studying blood vessel tissue from 674 patients, a research team has discovered how insulin contributes to the dysfunction of blood vessels in atherosclerosis, one of the most common chronic health conditions worldwide. Their research explains why insulin treatment fails to treat vessel damage in patients with diabetes and highlights a promising alternative therapy to correct insulin signaling and protect blood vessels. Insulin is a fundamental hormone in the body, as it regulates processes ranging from blood sugar control to chemical reactions in the cardiovascular system. Patients with type 2 diabetes often develop other chronic conditions such as heart disease and atherosclerosis, and research suggests that abnormal insulin signaling may be to blame. However, lowering blood sugar with insulin-like compounds has failed to reduce cardiovascular risk in diabetic patients. To understand why, Ioannis Akoumianakis and colleagues examined blood vessels from 674 patients with atherosclerosis who underwent coronary artery bypass surgery. They discovered that the patients' blood vessels were resistant to insulin - which normally controls the tone of blood vessels - and showed elevated levels of stress from harmful oxygen molecules. Instead, high levels of insulin correlated with more dysfunction in cells that line the insides of blood vessels. Treating the vessels with an experimental inhibitor of the enzyme DPP4 reduced oxidative stress and restored normal insulin activity, and chronic treatment with a DPP4 inhibitor reversed the damaging vascular effects of insulin in patients and in mice fed a high-fat diet. The authors conclude that future trials should explore the possibility of combining insulin treatment with DPP4 inhibitors to mitigate vessel damage in patients with atherosclerosis.

American Association for the Advancement of Science

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.